News & Articles

Join us Wednesday, November 18, to discover the impact metal interactions have on oligo analysis

Addition of CRISPR and RNAi offerings to complement PerkinElmer's life sciences and applied genomics solutions, with future opportunities to improve cell based discovery for precision medicine

This project aims to produce an antiviral and antifouling coating which can be used on PPE to protect staff working in healthcare settings

Join us Monday, November 16, to explore the advantages and applications of direct molecular testing

The StarBright Blue 700, StarBright Violet 440 and StarBright Violet 610 dyes aim to offer maximal brightness for improved resolution

From ultrafiltration and extraction to glycosylation and imaging, discover the latest technologies, top tips, and best practices for protein biology research

To expand Minimally Invasive Surgery field by reinforcing its orthopedics business

Company’s latest test enables differential diagnosis between COVID-19, flu and RSV infection

New sample collection kit enables convenient and safe collection, transportation and handling of pathogenic samples including COVID-19 and influenza

Study by University of Manchester reassures patients that it is safe to take blood pressure medication during the pandemic

Which new products made the most difference to your lab work this year?

New kit aims to provide highly sensitive and efficient approach for studying mitophagy impairment in conditions such as Parkinson’s and Alzheimer’s

The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance

Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies

The collaboration will focus on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy

Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days

Roche and Atea partner to jointly develop AT-527, an orally administered direct-acting antiviral (DAA) currently in Phase 2 clinical trials

Watch world-renowned experts and connect with leading innovators on the hottest topics, new developments and latest technologies in neuroscience

The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts

The company aims to meet the increased demand for approved media to maintain virus viability from sample collection to the lab

Join us Thursday, November 5, to learn how to introduce base editing technology into your cell therapy pipeline